Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E. I. Khatkova
Observed names:
E I Khatkova,
E. Khatkova,
E.I. Khatkova,
Evgenia Khatkova
Institution:
Moscow Clinical Scientific Center
Observed institutions:
Russian University of Medicine,
Moscow Clinical Scientific Center,
Ministry of Health of the Russian Federation,
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
ORCID:
0000-0002-0259-117X
Observed ORCIDs:
0000-0002-0259-117X,
0009-0001-2192-6537
OpenAlex ID:
A5012011624
Potential of primary drug prevention of cardiotoxicity in the context of anticancer therapy
2023
·
Yu. A. Vasyuk
, E. Y. Shupenina
, et al.
·
Russian Journal of Cardiology
·
5
PDF
Target therapy of luminal HER2-negative advanced breast cancer with PIK3CA mutation: combination of alpelisib plus fulvestrant in real clinical practice
2021
·
D. A. Filonenko
, T. M. Ibragimova
, et al.
·
Meditsinskiy sovet = Medical Council
·
3
PDF
Visual assessment of the Ki67 index in breast cancer using the global scoring
2022
·
I.M. Telezhnikova
, L.G. Zhukova
, et al.
·
CLINICAL AND EXPERIMENTAL MORPHOLOGY
·
2
PDF
Olaparib in the metastatic HER2-negative breast cancer setting
2020
·
L. G. Zhukova
, E. I. Khatkova
, et al.
·
Meditsinskiy sovet = Medical Council
·
2
PDF
Cytokine profiles in HPV-associated cervical intraepithelial neoplasia.
2026
·
Aleksandra Nikolaevna Riger
, Nataliy Kharchenko
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Cross-sectional study of treatment approaches of luminal HER2negative metastatic breast cancer in real practice in Moscow
2025
·
L. G. Zhukova
, K. S. Grechukhina
, et al.
·
Malignant tumours
·
1
PDF
Role of palbociclib in the treatment of hormone receptor-positive HER2-negative metastatic breast cancer. Generalizing results of randomized trials and real clinical practice
2019
·
L. G. Zhukova
, E. I. Khatkova
, et al.
·
Meditsinskiy sovet = Medical Council
·
1
PDF
Clinical factors associated with durable response to atezolizumab in extensive-stage small-cell lung cancer: A real-world analysis in Moscow.
2026
·
Evgenia Khatkova
, Demid Shchetinkin
, et al.
·
Journal of Clinical Oncology
Efficacy of immunotherapy-based regimens in Russian patients with EGFR -mutated metastatic NSCLC after EGFR TKI failure: A multi-institution real-world analysis.
2026
·
Sergei Smolin
, Lyudmila Zhukova
, et al.
·
Journal of Clinical Oncology
PDF
Efficacy of primary cardioprotection with perindopril, bisoprolol, and trimetazidine in high-risk patients with breast and gastric cancer receiving anthracycline- and trastuzumab-containing therapy.
2026
·
Evgenia Khatkova
, Evgenia Novosel
, et al.
·
Journal of Clinical Oncology
A Case of Primary Synovial Sarcoma of the Posterior Mediastinum: From Diagnostic Challenges to the Surgical Approach
2026
·
Parvin Akhmedov
, Arif Allakhverdiev
, et al.
·
The Korean Journal of Thoracic and Cardiovascular Surgery
PDF
104P Efficacy of abemaciclib following progression on prior CDK4/6i in HR+/HER2- metastatic breast cancer: Real-world experience in Moscow
2025
·
E. Khatkova
, E. Lukashova
, et al.
·
Annals of Oncology
P3.01.11 Lung Cancer in Young Patients Under 45 Years: Clinical Characteristics, Histology and Molecular Profile
2025
·
P. Akhmedov
, A. Allakhverdiev
, et al.
·
Journal of Thoracic Oncology
The use of regorafenib in patients with disseminated gastrointestinal stromal tumours. A review of the literature. A clinical case
2018
·
D. A. Filonenko
, S. V. Petukhova
, et al.
·
Meditsinskiy sovet = Medical Council
PDF
Optimal duration of adjuvant trastuzumab therapy in patients with HER2-possitive early breast cancer: whether the problem is resolved?
2018
·
L G Zhukova
, I P Ganshina
, et al.
·
Journal of Modern Oncology
Show more works
View as search
Works count:
15
Citation count:
16
H-index:
2
I10-index:
Year
Topic
Type